Renal Neoplasms
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma (NCT05119335) | NiKang Therapeutics, Inc. | 2021-10-26 |
| A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer (NCT03165721) | National Cancer Institute (NCI) | 2017-08-16 |
| A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment (NCT02688491) | First Affiliated Hospital, Sun Yat-Sen University | 2016-07-01 |
| Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. (NCT00199888) | Ludwig Institute for Cancer Research | 2005-06-01 |
Track Renal Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.